Lexicon Pharmaceuticals
LXRX
#6754
Rank
C$1.11 B
Marketcap
C$2.51
Share price
0.57%
Change (1 day)
18.31%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): C-$0.21

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.21. In 2025 the company made an earnings per share (EPS) of C-$0.20 an increase over its 2024 EPS that were of C-$0.91.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.215.16%
2025C-$0.20-78.13%
2024C-$0.91-20%
2023C-$1.1431.15%
2022C-$0.87-0%
2021C-$0.8710.91%
2020C-$0.78-145.08%
2019C$1.74-206.09%
2018C-$1.64-5.74%
2017C-$1.74-10.95%
2016C-$1.952640%
2015C-$0.07129-96.34%
2014C-$1.95-2.53%
2013C-$2.00-9.09%
2012C-$2.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$26.55-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.71-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.75-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.33 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$14.27-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02851-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.07 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$41.76 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA